论文部分内容阅读
目的:研究鞘内连续输注小剂量舒芬太尼用于分娩镇痛的临床效果及对分娩的影响。方法:40例单胎初产妇随机均分成两组,Ⅰ组为未镇痛组,Ⅱ组为鞘内舒芬太尼镇痛组。在2组孕妇“宫口开3 cm、1 h后、2 h后、4 h后、宫口开全时”监测VAS镇痛评分、子宫收缩力的变化,并记录第一、二产程时间、催产素的使用率、分娩方式以及胎儿Apgar评分等。结果:和Ⅰ组比较,分娩镇痛后Ⅱ组VAS镇痛评分明显降低(P<0.01),但2组孕妇的子宫收缩力,第一、二产程时间,催产素的使用率,分娩方式,以及胎儿Apgar评分等各项指标无显著性差异(P>0.05)。结论:鞘内连续输注小剂量舒芬太尼用于分娩镇痛镇痛效果良好,不影响孕妇的子宫收缩,第一、二产程,分娩方式,以及胎儿Apgar评分,是一种安全、满意的镇痛方法。
Objective: To study the clinical effect of intrathecal continuous infusion of sufentanil on labor analgesia and its effect on delivery. Methods: Forty primiparous single mothers were randomly divided into two groups. Group Ⅰ was non-analgesic group, group Ⅱ was intrathecal sufentanil analgesia group. In 2 groups of pregnant women “cervix open 3 cm, 1 h, 2 h, 4 h after the cervix open full time ” VAS analgesia score, uterine contractility changes, and record the first and second stage of labor Time, oxytocin use, mode of delivery, and fetal Apgar score. Results: Compared with group Ⅰ, the analgesic score of VAS in group Ⅱ decreased significantly after labor analgesia (P <0.01), but the uterine contractility, the time of first and second stage of labor, the usage of oxytocin, the mode of delivery, And fetal Apgar score and other indicators no significant difference (P> 0.05). CONCLUSIONS: Continuous intrathecal infusion of sufentanil at a low dose for labor analgesia has a good analgesic effect and does not affect uterine contractions, first and second stage of labor, mode of delivery and Apgar score of the fetus, which is safe and satisfactory The analgesic method.